Chinese nationalism

How do people get appointed to the House of Lords and can it ever change? The process explained

Retrieved on: 
Tuesday, July 4, 2023

However the Lords is an unelected house, which raises questions about what place it can have in a modern democracy.

Key Points: 
  • However the Lords is an unelected house, which raises questions about what place it can have in a modern democracy.
  • These have flared up with new vigour in the wake of former prime minister Boris Johnson’s resignation honours list, which contained multiple surprises.
  • With close to 800 members, the House of Lords is the second largest legislature in the world (behind only the Chinese National People’s Congress).
  • The absence of elections to the Lords, combined with its size and cost, makes the public perception of how people are appointed even more important.

Routes to the Lords

    • There are several ways to become a member of the House of Lords.
    • Prime ministers leaving office can recommend peerages in their resignation honours list for people who have supported them.
    • Historically, the most controversial of these routes have been the political and resignation honours lists – primarily because of perceptions of cronyism.

The appointments commission

    • The commission also has a role to play in vetting other nominations for propriety, including political appointments with a view to minimising potential reputational risks for the house.
    • The commission is not involved in the appointment process after providing that advice to the prime minster.
    • However, while the commission must vet the nomination, the final decisions are taken by the prime minister of the day.

Change in the air

    • This means that its role can be altered without seeking permission from parliament.
    • As recent events have shown, its advice can also be ignored, which has created a troublesome new precedent.
    • It is proposed this could have regard for the size of the chamber when making recommendations to the prime minister.

Olympian Table Tennis Player Lily Zhang Is Hopeful About WTT World Tour 2022 Thanks to Coach Zheng Pu’s Support and Training

Retrieved on: 
Thursday, March 31, 2022

Renowned table tennis player Lily Zhang is set to make history once again when she represents the US at the WTT World Tour in Singapore and Doha, Qatar.

Key Points: 
  • Renowned table tennis player Lily Zhang is set to make history once again when she represents the US at the WTT World Tour in Singapore and Doha, Qatar.
  • View the full release here: https://www.businesswire.com/news/home/20220331005043/en/
    Olympian Table Tennis player Lily Zhang is hopeful about WTT World Tour 2022 thanks to Coach Zheng Pus support and training (Photo: Business Wire)
    Lily, 25, made history when she won the US a bronze medal in the mixed doubles category of the 2021 World Table Tennis Championships Finals held in Houston.
  • The accomplished athlete, who is a three-time Olympian, made history last year when she brought the US its first table tennis medal in 62 years.
  • Coach Zheng Pu has immense faith in his pupil Zhangs ability to score more accolades for the US in the WTT World Tour.

Onconova Therapeutics Regains Rigosertib Rights in Greater China

Retrieved on: 
Thursday, January 23, 2020

The Greater China territory, including mainland China, Hong Kong, Macau and Taiwan, represents one of the key world pharmaceutical markets.

Key Points: 
  • The Greater China territory, including mainland China, Hong Kong, Macau and Taiwan, represents one of the key world pharmaceutical markets.
  • We are pleased to regain rigosertib rights for Greater China, and we are encouraged by the opportunity to partner rigosertib in select territories including Greater China as we approach the potential corporate catalyst of topline data for the registrational INSPIRE Trial in 1H 2020, said Dr. Steven Fruchtman, President and Chief Executive Officer of Onconova.
  • We thank HanX for their collaborative efforts to advance rigosertib in this key market including the filing of the rigosertib IND in China.
  • The United States, Europe, and Greater China represent the major pharmaceutical markets Onconova directly controls heading into INSPIRE data read out.

We choose dialogue, not conflict

Retrieved on: 
Wednesday, May 22, 2019

Focusing on the keyword "civilization," participants shared their experiences on governance, and discussed such topics as the diversity of civilizations.

Key Points: 
  • Focusing on the keyword "civilization," participants shared their experiences on governance, and discussed such topics as the diversity of civilizations.
  • Various activities, including an Asian Culture Carnival, Asian Cuisine Festival and Asian Film and TV Week, added allure to this unprecedented event.
  • Likewise, different civilizations have different charms, which makes it difficult to sum up Asian culture in one simple word.
  • China took this opportunity to call on all countries to respect each other, and treat each other as equals amid diversity.

RepliCel Life Sciences Announces Signed Licensing and Co-Development Deal for Greater China

Retrieved on: 
Wednesday, July 11, 2018

The deal between the parties represents an investment in RepliCel by YOFOTO along with milestone payments, minimum program funding commitments, and sales royalties in exchange for an exclusive 15-year license to three of RepliCel products for Greater China (Mainland China, Hong Kong, Macau, and Taiwan) (the "Territory").

Key Points: 
  • The deal between the parties represents an investment in RepliCel by YOFOTO along with milestone payments, minimum program funding commitments, and sales royalties in exchange for an exclusive 15-year license to three of RepliCel products for Greater China (Mainland China, Hong Kong, Macau, and Taiwan) (the "Territory").
  • "In 2017 RepliCel delivered successful phase I data in all three of its cell therapy programs and functioning prototypes of its next-generation dermal injector," stated RepliCel President & CEO, R. Lee Buckler.
  • The partnership with YOFOTO represents such a deal and provides RepliCel with not only an outstanding partner in Greater China but capital to move our programs forward in Europe and North America."
  • View original content with multimedia: http://www.prnewswire.com/news-releases/replicel-life-sciences-announces...
    SOURCE RepliCel Life Sciences Inc.